文献速递慢阻肺

CAPTURE慢阻肺筛查工具在美国基层医疗中的影响:整群随机试验

Impact of the CAPTURE Chronic Obstructive Pulmonary Disease Screening Tool in U.S. Primary Care: A Cluster-Randomized Trial.
PubMed 文献 · Am J Respir Crit Care Med · 2025-01-01

该整群随机试验纳入49家常规照护和51家干预(COPD与CAPTURE教育加筛查评分)基层诊所,评估CAPTURE筛查对临床行为与患者结局的影响。387例CAPTURE阳性患者中,主要复合结局两组无显著差异(45.9% vs 41.9%,P=0.47),仅肺功能转诊/完成率干预组更高(绝对差10.4%,P=0.0465)。1028例CAPTURE阴性患者结局相似;疫情前干预组资源配置更合理,疫情期间差异减弱。

要点

  • CAPTURE筛查评分未改善阳性患者的主要复合结局。
  • 干预组仅肺功能转诊/完成率提高10.4%。
  • 疫情前干预组对阴性患者更少评估COPD,资源利用更合理。

核心结论

  • 在参与研究的美国基层诊所中,COPD与CAPTURE教育加筛查评分未改变医生对CAPTURE阳性患者的COPD评估、照护或患者结局。
  • 疫情前CAPTURE阳性患者更可能完成肺功能转诊,而CAPTURE阴性患者被评估COPD的可能性显著降低,提示干预可能促进更合理的医疗资源利用。

研究设计与样本

  • 整群随机试验,纳入49家常规照护(仅COPD教育)和51家干预(COPD与CAPTURE教育加筛查评分)基层诊所。
  • 收集CAPTURE筛查评分升高或研究肺功能异常患者12个月的病历与患者调查结局数据。
  • CAPTURE阳性患者387例,CAPTURE阴性患者1028例。
  • 试验注册于www.clinicaltrials.gov(NCT03581227)。

主要发现

  • CAPTURE阳性患者主要复合结局(肺功能转诊/完成、新COPD诊断、新处方长效吸入药物、呼吸专科转诊、肺康复转诊/完成)两组无显著差异:45.9% vs 41.9%(绝对差4.0%,95%CI -6.9至15.0,P=0.47)。
  • 仅肺功能转诊/完成率干预组更高:绝对差10.4%(95%CI 0.1至20.7,P=0.0465)。
  • 次要结局、复合组分、CAT评分变化、呼吸疾病发生率或住院率均无差异。
  • CAPTURE阴性患者的主要复合结局和所有次要结局两组相似。
  • 疫情前干预组对CAPTURE阳性和阴性患者的临床与患者结局存在差异,疫情期间差异减弱。

关键数值与推荐

  • CAPTURE阳性患者主要复合结局:常规照护组45.9% vs 干预组41.9%(绝对差4.0%,95%CI -6.9至15.0,P=0.47)。
  • 肺功能转诊/完成率绝对差10.4%(95%CI 0.1至20.7,P=0.0465),干预组更高。

临床怎么用

  • 在基层医疗中使用CAPTURE筛查评分联合教育,可能提高阳性患者肺功能转诊完成率。
  • 对筛查阴性患者,该干预可能减少不必要的COPD评估,促进资源合理利用。
  • 需注意疫情可能削弱干预效果,实施时应考虑外部环境的影响。

局限性

  • 主要复合结局各组分之效应可能被复合终点掩盖。
  • 结果基于美国基层诊所,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: The impact of screening for chronic obstructive pulmonary disease (COPD) on U.S. primary care clinician behavior and patient outcomes is unclear. Objectives: We sought to assess the impact of receiving screening scores for clinical and patient outcomes using the COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURE) tool. Methods: This cluster-randomized trial included 49 usual-care (COPD education only) and 51 intervention (COPD and CAPTURE education plus screening scores) primary care practices. Twelve-month medical record and patient survey outcome data were collected from patients with elevated screening scores or study spirometric abnormalities. Measurements and Main Results: Among 387 CAPTURE screen-positive (CAPTURE+) patients, no significant difference was noted between usual-care and intervention practices in the primary composite outcomes of 1) spirometry referral/completion, or 2) new COPD diagnosis, or 3) newly prescribed inhaled long-acting respiratory medication, or 4) referral to a respiratory specialist, or 5) pulmonary rehabilitation referral/completion; 45.9% versus 41.9%, respectively (absolute difference, 4.0%; 95% confidence interval, -6.9, 15.0; P = 0.47). Only spirometry referral/completion was higher in the intervention group (absolute difference, 10.4%; 95% confidence interval, 0.1, 20.7; P = 0.0465). No differences were noted for secondary outcomes, composite components, change in COPD Assessment Test scores, rates of respiratory illnesses, or hospitalizations. For the 1,028 CAPTURE screen-negative (CAPTURE-) patients, composite primary and all secondary outcomes were similar in the two arms. In secondary and post hoc analyses evaluating the potential impact of the pandemic, intervention group differences in clinician and patient outcomes were noted for CAPTURE+ and CAPTURE- patients in the prepandemic period that diminished during the pandemic. Conclusions: Within these U.S. primary care practices, COPD and CAPTURE education plus receipt of CAPTURE screening scores did not change clinician COPD assessment or care or patient outcomes for CAPTURE+ patients. However, in the prepandemic period, CAPTURE+ patients were more likely to undergo spirometry referral completion, whereas for CAPTURE- patients, clinicians were significantly less likely to assess for COPD, suggesting that the intervention resulted in a more appropriate use of healthcare resources. Clinical trial registered with www.clinicaltrials.gov (NCT03581227).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Martinez, Yawn, Angulo, et al. Impact of the CAPTURE Chronic Obstructive Pulmonary Disease Screening Tool in U.S. Primary Care: A Cluster-Randomized Trial. Am J Respir Crit Care Med. 2025. PMID: 39715575. doi:10.1164/rccm.202405-0921OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。